Steven Chamow, PhD
Dr. Steven Chamow is a recognized expert in monoclonal antibodies and derivatives. He served as president of CMC advisory firm Chamow & Associates, acquired by Alira Health in 2021. Over his career, he has contributed to the development of four marketed biologics. Accolades include notable work at Intradigm, Genitope, Abgenix and Genentech. He earned degrees at the University of California (B.A. Santa Cruz, PhD. Davis) and did postdoctoral training at NIH.
Key areas of expertise
- Monoclonal Antibodies and Derivatives
- Characterization and Analysis of Biologics
- Recombinant Glycoprotein Production
- Scale Up and GMP Manufacture of Biologics